Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I don't have a million shares yet so I'm hoping this continues to drop so I can buy more. Sorry to the weak hands with their short sighted views.
This is exactly the kind of company I'm looking to invest in at this penny stock level. 1. The science is undeniable- companies are already using biologics to treat joint problems. Whether its PRP,
Great Post and recap of all the potential with Intellicell. I was looking for another Benitec type of stock performer and this might be it. They clearly have the superior technology when it comes to
Harvesting ASCs for autologous use. I will be buying more tomorrow and any chance I get on dips. In this stem cell race, it's hard to find the hidden gems. This company has a chance to be a dominate player in an industry that will dominate healthcare. Science has only begun to scratch the potential of stem cells. With their patented, cost effective, and quality assured extraction of stem cells, Intellicell will be the global supplier and corner the market on ASCs for autologous use. It's like having the most pure cocaine at the best price in a block full of crackheads. Lol!
Yeah! One more day closer to you know what.
Hope to get some cheapies tomorrow.
Yahoo Finance has the market cap at $1.74 million. Is this true?
Thanks Gem. Based on their data, I really think their platform is the most superior in the realm of extracting stem cells from adipose tissue. One other question: I have read that the FDA might have some issues in regards to categorizing their treatment as cell/tissue product vs drug/biological in which case they would not be allowed to offer their treatments without going through the FDA approval process. Where does the company stand in respect to this issue with the FDA?
Question for the board: I know the company has supplied doctors with their stem cells for patient use ( ~300 patients) for various conditions. They are able to do so because of their unique platform in harvesting the cells. 1) how much compensation does Intellicell receive for the cells/treatment? 2) are those procedures covered through the patient's insurance or are these cash patients? I assume these treatments would be cash only as these procedures, although safe and effective, would be considered experimental as they have not gone through with FDA approval to be classified as an indication. Thanks in advance.
So happy to stumble upon this stock. I love RM companies because that is the future of medicine. Initiated a small position and will continue the DD. Looking forward to getting more. Average up or average down, either way is fine with me because this one is a long term keeper.
Nice to see the strong support at the 3s for the last few days. That's a good sign. I hope people on the fence, flippers and bashers aren't holding their breath and waiting for 2s much longer. Every passing day, brings imminent rocket fuel one day closer. So here's the risk: buy now and it could slip into the 2s in which case you could buy more (and a lot of us will) or sit and hope to get some 2s ( slim chance). The reward: FDA approval and bye bye sub penny land forever! Investing is all about minimizing risk and maximizing reward. BMSN at these levels is almost a slam dunk! Just IMHO.
Thanks for the info. I'm sure this funding will be approved and is a good vote of confidence by the institutional investors in Benitec. Needless to say, being able to secure funds for all their ambitious programs was a top priority and I'm happy that they can now just focus on execution of their trials.
I don't concern myself with semantics. For every transaction there is a buyer and a seller.
Good for you Stock Ninja!
My new mission is to get as much Benitec shares as possible. This is a multi-billion dollar company in the making.
What numbnut sold 1.4 mil shares at .0001 when he could sell at .0002 all day or maybe even .0003?
Bashers and flippers want to get in lower so bad because they know how fast this thing can rocket when news hit. They continually shake the tree and hope for weaks to sell. FDA approval will make the last jolt to .009 look like a crawl. True longs aren't worried about this temporary decline because there's nothing to worry about. Everything is still intact and just awaiting news. I don't even want to speculate of why BMSN is being quiet. I'm not management and they also want a higher PPS so I'll trust them to do what's best. Good luck to everyone who wants a piece of the BMSN pie, I just feel bad for those that sell for a loss because everyone here (bashers, flippers, longs, everyone but the weak) knows that the PPS and BMSN pie is going to grow a whole lot bigger. Then you'll get a whole new set of different kinds of investors wanting a bigger piece of the pie. IMO
Wow! Haven't seen 3s in awhile! Something must be brewing.
Read up on gene silencing. Cancer cells are able to evade detection and execution from our immune system by activating certain genes that suppresses the immune system. This helps to explain how cancers develop resistance to chemo and spread. Silencing those genes allows our immune system to better fight the cancer cells and increases a person's survivability. No harm to healthy cells, no toxicity, dd-RNAi from Benitec also is the best method because it requires only 1 time intervention. Safe and effective. If proven effective, it will pave the way for new treatment for breast cancer and many other potential cancers. A new standard of care. That's why this would be such a huge deal. Needless to say, the profits would be in the Billions.
I'm with TD Ameritrade and just saw my accounts with the Regen shares. It's just a waiting game now.
True. That's another way to look at it. I guess I should look at it more like that. Like I said. We are on the same team. I would love for BMSN to continue to flourish along side Regen. Who knows BMSN might just surprise everybody and create something new.
I understand the math. I want BMSN to do well just as much as anyone. (i have 3.8 million reasons to cheer them on), but don't you realize that Regen is the only real asset that this company has. I could care less for ENTB. Regen is the only reason I invested with BMSN. Before the Divy they owned 99% of Regen, after the Divy they will own 58% of Regen. No matter how valuable Regen becomes 99% is better than 58%. Don't get me wrong, I'm thankful for the Divy Regen shares because I believe it indicates upcoming FDA approval. The only value creation is when we get developing news such as FDA approval, IND for Dcellvax or IND for Hemexcellerate II, or other material facts. That's just my opinion.
It's true Gmayes, the divys creates value for one company and detracts from the other and the net gain is zero. They just can't create value by transferring shares. The value is created by FDA approval. The divy and upcoming IPO is a clear indication that positive FDA news is imminent. That's why I'm excited. Owning shares of Regen pre-iPO will be awesome.
Thanks for clearing things up. I'm sure we will get FDA news before Regen's IPO.
I amNew to Cel-Sci and saw an article describing that Multikine was shown to have a significant lowering effect on total cholesterol without any liver toxicity. This was shown during their phase II trial. Imagine if Multikine is proven to work for both cancers and lowering cholesterol. What a blockbuster treatment!
Agree. I think Koos will announce major news before any trading action starts with Regen. The only thing that matters to me is FDA approval. We get that and things will be Great.
Thanks d5. I think I saw this awhile back also. I saw another prospectus for a different company and their IPO prospectus gave an actual offering price and not just a par value. I guess I was just hoping to see something in writing with a fair price estimate. We will know soon enough. GLTA.
Anyone know when we should expect to see a prospectus regarding the Upcoming Regen IPO? That would be great to see their initial offering price.
Thanks Traz. I agree. If the market caps for both companies are out of proportion to the ratio I had mention, then it would make sense to take advantage of that. And this doesn't take into account any future developments by BMSN to venture out on their own to develop other projects under their umbrella and away from Regen. I guess we will have to wait and see when Regen starts trading. Thanks for the feedback.
Thanks for the opinion. What are some other positive things that BMSN has going other than Regen? All of their pipeline is under Regen. I don't mind holding BMSN after Regen is being traded, but its got to be at a discount to Regen because that's where all the developing pipeline is at. Please expand. Thanks.
I guess that will all depend on the PPS of both stocks and the relative market cap of both companies. I assume people want BMSN so they can get exposure to Regen, so buying Regen shares gets you 100% Regen while buying BMSN gets you 58% exposure. IMO BMSN market cap would have to be at a 42% discount or more as compared to Regen for it to make sense. Unless of course you are excited about what ENTB, their other subsidiary is doing. Just my opinion. I appreciate the feedback and alternative perspectives.
I have been strong on BMSN from the start due to their full ownership of Regen. I do have concerns for the PPS of BMSN once Regen is trading independently. I realizeBMSN will still
have a 58% stake in Regen, but all the exiting stuff is happening with Regen. Wouldn't people just shift their holdings into Regen and abandon BMSN once they have the opportunity. What are your thoughts? Appreciate the feedback.
There is obviously a lot of speculation on what the pps of Regen shares will be at the IPO. I know some great posts have alluded to the price at $1.00 from previous BMSN filings and transactions involving Regen shares. IMO it's all going to depend on the news leading up to the IPO. BMSN is not going to introduce their star pupil as an FDA reject, but will roll out the red carpet for their newly approved clinical stage company Regen. And when that happens it will be at least a $50 million market cap company- probably a lot higher given the small float and the likelihood of orphan drug status. ( just don't want to be labeled a pumper). To think , some people still think this is all a scam- like everyone on the company's board, the FDA, the scientists are all in cahoots to steal their money. I appreciate all the opposing views because it allows for thoughtful analysis, but if you don't see the writing on the wall, we longs can take you to river, but we can't make you drink jack asses.
My sentiment on Benitec is very bullish. There is a great reason BMSN chose their delivery platform for gene silencing. It is the best in class bar none. If you're talking great things about Benitec to me you are preaching to the choir. Go BMSN-
Recently new proud part owner of this company. I dipped my toes in last week and I guess I'll just have to accumulate more and average up. This is just the start. Sometimes it's about being at the right place at the right time. The early shareholders really paved the way by allowing the company to build the foundation for the science and manufacturing. All the heavy lifting has been done, now we sit and wait for phase III results, which only needs to prove a 10% increase for survival rate over control. Phase II data showed a 35% improvement of survival. This one is real simple. Grab as many shares as you can. Cheer for good days, jump for joy on pullbacks so you can grab more. The science is awesome and the application is too numerous to list.
What's the deal with this late surge? Could it be anticipation of FDA approval that is imminent? This a clear and present danger for shorts and they must cover!
Very nice. I'm glad we have some clarification on when we will get the shares. IMO, news of IND approval will come before we get the new Regen shares and definitely before Regen gets its ticker and starts trading. The window is rapidly closing for anyone to get in before sub-penny.
IMO, the FDA approval for hemexcellerate is as good as done. They wouldn't go through the trouble of an IPO unless written approval is imminent. This is the most important catalyst and it will take Regen to a clinical stage company. If you're patient and can wait for this announcement you will be rewarded. In the meantime the market will scare the doubters to rid their shares. I already know the approval is coming real soon. Just can't tell you exactly when.
That is a great sign for Aemd and is under appreciated by the market. This helps them with patient recruitment in both establishing the safety and efficacy as well as a huge patient base that can benefit once the procedure is approved and reimbursable. They have opportunities in both diagnostics, therapy, and as a test to monitor the effectiveness of treatment and the progression of a disease. Oh btw, they just identified bio markers for degenerative brain diseases which are difficult to diagnose or monitor progression.
Dividend news was nice, but most of us already expected that to happen. I think chances are great that they will announce FDA approval real soon. Why else would they schedule an IPO for Regen if they weren't confident about starting clinical trials soon? We all know what's going to happen when that happens.
Gene silencing is the future of healthcare and Benitec's ddRNAi will be the gold standard because of it's "one shot" approach. Can't wait for my funds to clear and load.